CI

At a glance

ClinicalIndex Comparison Record
N/ACompleted· 11 enrolled
Drug / intervention
iPro2 glucose sensor attachmentdevice
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT01980914
NCT01980914N/ACompleted

Impact of Hypoglycemia on Cardiac Function in Elderly Patients With Diabetes

University of British Columbia·interventional·Posted Nov 11, 2013·Updated Mar 16, 2020

In Brief

A clinical study evaluating iPro2 glucose sensor attachment for Hypoglycemia and Type 2 Diabetes. Completed, enrolled 11 participants across 1 site.

Detailed Summary

The risk of hypoglycemia (low blood sugar) associated with the treatment of diabetes increases with age. Hypoglycemia is a common reason for admission to hospital for older patients with diabetes. Older patients are often unaware that their blood sugar is low and asymptomatic hypoglycemia, as assessed by continuous blood sugar monitoring, is frequent in the elderly. There is also evidence that older people with diabetes are more likely to develop cardiovascular events such a heart attack and more likely to die suddenly when compared to older people without diabetes. It is possible that low blood sugar levels contribute to the increased frequency of these events, but this possibility has never been studied. The purpose of this study is to assess how frequently low blood sugar occurs in older patients with diabetes and to see if low blood sugars adversely affect heart function in these patients.

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
CountriesCanada
CollaboratorsIcentia UK

Timeline

N/ACompletedFinished
2014201520162017201820192020202120222023202420252026
First PostedNov 11, 2013
Enrollment StartMar 1, 2015
Primary CompletionSep 1, 2019
TodayJul 2, 2026
Enrollment to primary: 4.5 yearsPosted 12.6 years ago

Interventions

iPro2 glucose sensor attachmentdevice

At the same time the glucose sensor is started, a trained research nurse will connect the patient to an Icentia CardioSTAT, a continuous ambulatory ECG cardiac monitor.